CENTESSA PHARMACEUTICALS-ADR (CNTA) Stock Cash Flow
NASDAQ:CNTA - US1523091007 - ADR
16.79 USD
-0.21 (-1.24%)
16.45 USD
-0.34 (-2.03%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -229.90M | -235.76M | -151.09M | -216.21M | -381.07M | |||
| Depreciation Amortization | 900.00K | 940.00K | 810.00K | 130.00K | 30.00K | |||
| Change In Working Capital | 20.00M | 24.00M | -44.00M | -5.69M | -5.84M | |||
| Interest Paid | 9.25M | 10.00M | 9.91M | 7.28M | 1.48M | |||
| Taxes Paid | 1.07M | 80.00K | 2.94M | 1.30M | N/A | |||
| Other non cash items | 64.00M | 68.00M | 33.00M | 21.22M | 251.76M | |||
| OPERATING CASH FLOW | -144.00M | -142.00M | -160.00M | -200.55M | -135.11M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -30.00K | -170.00K | -1.14M | -190.00K | |||
| Other Investing Activity | -192.00M | 31.00M | -127.00M | 210.00K | 63.44M | |||
| INVESTING CASH FLOW | -192.00M | 31.00M | -127.00M | -930.00K | 63.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -760.00K | N/A | 0.00 | 73.93M | |||
| Stock Issued/Repurchased | 261.58M | 371.00M | 21.00M | 720.00K | 586.50M | |||
| Other Financing Activity | -7.45M | -5.32M | 0.00 | -260.00K | -280.00K | |||
| FINANCING CASH FLOW | 253.69M | 365.00M | 21.00M | 460.00K | 660.15M | |||
| Exchange Rate Effect | -500.00K | 1.23M | 620.00K | -420.00K | 1.82M | |||
| CHANGE IN CASH | -82.81M | 255.23M | -265.38M | -201.44M | 590.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -144.00M | -142.00M | -160.00M | -200.55M | -135.11M | |||
| Capital Expenditure | N/A | -30.00K | -170.00K | -1.14M | -190.00K | |||
| FREE CASH FLOW | -144.16M | -142.03M | -160.17M | -201.69M | -135.30M | |||
All data in USD